Unveiling new targets in LAR triple-negative breast cancer: ERBB2 mutations and senescence
Unveiling new targets in LAR triple-negative breast cancer: ERBB2 mutations and senescence
Apr 25, 2026 | Business
Unveiling new targets in LAR triple-negative breast cancer: ERBB2 mutations and senescence
Apr 25, 2026 | Business
Creative Biolabs' one-stop microfluidic platform accelerates biomedical breakthroughs by streamlining chip innovation for faster, scalable, and physiologically relevant discoveries.
Apr 24, 2026 | Lifestyle
H.B. Plant High School Launches First-Ever Dance Marathon to Support Children's Miracle Network
Apr 24, 2026 | Entertainment
In the new episode of Take It or Leave It, Dr. Barbara Taber does a deep-dive into recent ICE actions, broadening the focus and getting to the heart of the matter in record time.